Concepedia

Helen Ma

HM

33

Publications

2.7K

Citations

24

H-Index

2007

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Chinese University of Hong Kong

Columbia University Irving Medical Center

Prince of Wales Hospital

Dana-Farber Cancer Institute

Helen Ma is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cancer research, and cell biology.

ORCID

Top concepts

Publications per year

2007–2024

33

Publications

33

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Jennifer R. Molina, Yuting Sun, Marina Protopopova et al. · Nature Medicine · 2018 · 903 citations · Full text

, , +4

Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes

Polina Matre, Juliana Vélez, Rodrigo Jácamo et al. · Oncotarget · 2016 · 186 citations · Full text

Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study

Lorenzo Falchi, Helen Ma, Sandra E. Klein et al. · Blood · 2020 · 174 citations · Full text

Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia

Qi Zhang, Bridget Riley‐Gillis, Lina Han et al. · Signal Transduction and Targeted Therapy · 2022 · 168 citations · Full text

MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199

Juliana M. Benito, Laura Godfrey, Kensuke Kojima et al. · Cell Reports · 2015 · 152 citations · Full text

, , +15

Rows per page

1–5 of 33